American Vietnamese Biotech Incorporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was VND 54,877.18 million compared to VND 79,120.42 million a year ago. Net income was VND 2,739.59 million compared to VND 33,802.71 million a year ago. Basic earnings per share from continuing operations was VND 14 compared to VND 344 a year ago.
For the six months, revenue was VND 97,810.66 million compared to VND 126,817.35 million a year ago. Net income was VND 5,229.41 million compared to VND 46,115.24 million a year ago. Basic earnings per share from continuing operations was VND 40 compared to VND 479 a year ago. Diluted earnings per share from continuing operations was VND 40 compared to VND 479 a year ago.